Results 11 to 20 of about 5,611,155 (244)

Kaposi Sarcoma of Childhood: Inborn or Acquired Immunodeficiency to Oncogenic HHV-8. [PDF]

open access: yesPediatr Blood Cancer, 2016
Kaposi sarcoma (KS) is an endothelial malignancy caused by human herpes virus‐8 (HHV‐8) infection. The epidemic and iatrogenic forms of childhood KS result from a profound and acquired T cell deficiency.
Jackson CC   +6 more
europepmc   +2 more sources

Cidofovir on Hhv-8 in Bcbl-1 Cells [PDF]

open access: bronzeAntiviral Therapy, 2004
SHORT COMMUNICATION: abstract non ...
PICA, FRANCESCA   +3 more
openaire   +8 more sources

Localisation of HHV-8 in AIDS related lymphadenopathy [PDF]

open access: bronzeMolecular Pathology, 2000
Many lymph node abnormalities have been described in AIDS. These include opportunistic infections that sometimes result in spindle cell pseudotumours, Kaposi's sarcoma (KS), malignant lymphoma (Hodgkin's and non-Hodgkin's), and florid reactive hyperplasia.
O'Leary, J J   +15 more
openaire   +6 more sources

Clinical and pathological characteristics of HIV- and HHV-8-negative Castleman disease.

open access: yesBlood, 2017
Castleman disease (CD) comprises 3 poorly understood lymphoproliferative variants sharing several common histopathological features. Unicentric CD (UCD) is localized to a single region of lymph nodes.
Yu L   +16 more
europepmc   +2 more sources

International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease.

open access: yesBlood, 2017
Human herpesvirus-8 (HHV-8)-negative, idiopathic multicentric Castleman disease (iMCD) is a rare and life-threatening disorder involving systemic inflammatory symptoms, polyclonal lymphoproliferation, cytopenias, and multiple organ system dysfunction ...
Fajgenbaum DC   +37 more
europepmc   +2 more sources

HHV-8 and EBV Positive Lymphoproliferative Disease: A Challenging Case. [PDF]

open access: yesTurk Patoloji Derg, 2022
Human herpes virus-8 (HHV-8) is linked to four lymphoproliferative diseases: primary effusion lymphoma, HHV-8 positive multicentric Castleman disease (MCD), HHV-8 positive diffuse large B cell lymphoma and HHV-8 positive germinotropic lymphoproliferative
Bülbül G, Gül G, Özcan MA, Özkal S.
europepmc   +2 more sources

HHV-8 reduces dendritic cell migration through down-regulation of cell-surface CCR6 and CCR7 and cytoskeleton reorganization [PDF]

open access: goldVirology Journal, 2012
For an efficient immune response against viral infection, dendritic cells (DCs) must express a coordinate repertoire of receptors that allow their recruitment to the sites of inflammation and subsequently to the secondary lymphoid organs in response to ...
M. Cirone   +8 more
semanticscholar   +2 more sources

Prevalence and Risk Factors of Human Herpes Virus Type 8 (HHV-8), Human Immunodeficiency Virus-1 (HIV-1), and Syphilis among Female Sex Workers in Malindi, Kenya. [PDF]

open access: yesInterdiscip Perspect Infect Dis, 2019
The prevalence of Human Herpes Virus type 8 (HHV-8), Human Immunodeficiency virus (HIV), and syphilis is high in Sub-Saharan Africa. Studies on HHV-8 in Kenya are few and data on its coinfection with HIV and syphilis scanty.
Nzivo MM   +4 more
europepmc   +2 more sources

HHV-8-encoded viral IL-6 collaborates with mouse IL-6 in the development of multicentric Castleman disease in mice.

open access: greenBlood, 2012
Human herpes virus 8 (HHV-8) or Kaposi sarcoma-associated herpes virus is the etiologic agent of Kaposi sarcoma, primary effusion lymphoma, and plasma cell-type multicentric Castleman disease (MCD).
Jan Suthaus   +8 more
semanticscholar   +3 more sources

Productive infection of HUVEC by HHV-8 is associated with changes compatible with angiogenic transformation

open access: yesEuropean Journal of Histochemistry, 2009
Kaposi’s Sarcoma (KS) is an angioproliferative disease associated with human herpesvirus 8 (HHV-8) infection.We have characterized the morphologic and phenotypic modifications of HUVEC in a model of productive HHV-8 infection.
C Foglieni   +6 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy